PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.86%
Negative revenue growth while IXX.DE stands at 22.81%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.84%
Negative gross profit growth while IXX.DE is at 10.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
-114.18%
Negative EBIT growth while IXX.DE is at 94.62%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-114.18%
Negative operating income growth while IXX.DE is at 5.56%. Joel Greenblatt would press for urgent turnaround measures.
-253.35%
Negative net income growth while IXX.DE stands at 117.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-227.81%
Negative EPS growth while IXX.DE is at 118.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-227.81%
Negative diluted EPS growth while IXX.DE is at 118.75%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
20.00%
Slight or no buybacks while IXX.DE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
20.00%
Slight or no buyback while IXX.DE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.90%
AR growth of 21.90% while IXX.DE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
36.00%
We show growth while IXX.DE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
42.26%
Asset growth above 1.5x IXX.DE's 5.03%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-16.04%
We have a declining book value while IXX.DE shows 8.32%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
119.20%
We have some new debt while IXX.DE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
3.25%
SG&A declining or stable vs. IXX.DE's 12.56%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.